Loading component...

Recommended Insights

Inflation Reduction Act: CMS Publishes Final Guidance for Initial Price Applicability Year 2028
October 9, 2025
Global Life Sciences Update
Major U.S. Government Price Reporting Proposals Warrant Industry Comment
July 18, 2025
Global Life Sciences Update
Key Inflation Reduction Act Amendment Broadens U.S. Protection for Orphan Drugs
July 15, 2025
Global Life Sciences Update
CMS Sets Stage for 2028 Medicare Drug Price Negotiations — First Look at Negotiations for Part B
May 21, 2025
Global Life Sciences Update
Drug Pricing Executive Order Aims to End Inflation Reduction Act “Pill Penalty,” Resurrect Policies From First Trump Administration
April 17, 2025
Global Life Sciences Update
Medicare Part D’s New Cost-Smoothing Program: Key Insights and Impacts
September 17, 2024
Healthcare Update
Navigate Investment and Drug Development Under the IRA
January 1, 2024Global IR @JPMorgan Healthcare Conference
Watch
IRA Considerations for Life Sciences Investors
October 19, 2023Biotechnology Innovation Organization
Watch
Inflation Reduction Act: CMS Releases New “Medicare Drug Price Negotiation Program” Guidance as Industry Lawsuits Mount
July 14, 2023
Global Life Sciences Update
Impact Of Inflation Reduction Act On Drug Development For U.S. Market
May 23, 2023
GoodLifeSci
HHS Faces IRA Implementation Risk Without Notice and Comment
April 3, 2023
Global Life Sciences Update
Navigating The IRA: What Biopharmas Need To Know
March 30, 2023Presented by BioCentury and Putnam
Webinar
Inflation Reduction Act: CMS Solicits Comments on Price Negotiation Program Guidance, Makes Part B Coinsurance Announcements
March 20, 2023
Global Life Sciences Update
U.S. Inflation Reduction Act Implementation: Public Opportunities to Comment on New Medicare Inflation Rebates Program
February 17, 2023
Global Life Sciences Update
Inflation Reduction Act Implementation: Serious Hurdles to Accurately Calculating Medicare Part B Inflation Rebates
February 14, 2023
Global Life Sciences Update

• Global Life Sciences Update

  Inflation Reduction Act: CMS Publishes Final Guidance for Initial Price Applicability Year 2028

  October 9, 2025
• Global Life Sciences Update

  Major U.S. Government Price Reporting Proposals Warrant Industry Comment

  July 18, 2025
• Global Life Sciences Update

  Key Inflation Reduction Act Amendment Broadens U.S. Protection for Orphan Drugs

  July 15, 2025
• Global Life Sciences Update

  CMS Sets Stage for 2028 Medicare Drug Price Negotiations — First Look at Negotiations for Part B

  May 21, 2025
• Global Life Sciences Update

  Drug Pricing Executive Order Aims to End Inflation Reduction Act “Pill Penalty,” Resurrect Policies From First Trump Administration

  April 17, 2025
• Healthcare Update

  Medicare Part D’s New Cost-Smoothing Program: Key Insights and Impacts

  September 17, 2024
• Watch

  Navigate Investment and Drug Development Under the IRA

  January 1, 2024Global IR @JPMorgan Healthcare Conference
• Watch

  IRA Considerations for Life Sciences Investors

  October 19, 2023Biotechnology Innovation Organization
• Global Life Sciences Update

  Inflation Reduction Act: CMS Releases New “Medicare Drug Price Negotiation Program” Guidance as Industry Lawsuits Mount

  July 14, 2023
• GoodLifeSci

  Impact Of Inflation Reduction Act On Drug Development For U.S. Market

  May 23, 2023
• Global Life Sciences Update

  HHS Faces IRA Implementation Risk Without Notice and Comment

  April 3, 2023
• Webinar

  Navigating The IRA: What Biopharmas Need To Know

  March 30, 2023Presented by BioCentury and Putnam
• Global Life Sciences Update

  Inflation Reduction Act: CMS Solicits Comments on Price Negotiation Program Guidance, Makes Part B Coinsurance Announcements

  March 20, 2023
• Global Life Sciences Update

  U.S. Inflation Reduction Act Implementation: Public Opportunities to Comment on New Medicare Inflation Rebates Program

  February 17, 2023
• Global Life Sciences Update

  Inflation Reduction Act Implementation: Serious Hurdles to Accurately Calculating Medicare Part B Inflation Rebates

  February 14, 2023

Load More

Contacts

合伙人律师

Meenakshi Datta

mdatta@sidley.com

芝加哥+1 312 853 7169

合伙人律师

Elizabeth Hardcastle

ehardcastle@sidley.com

旧金山+1 415 772 7447

合伙人律师

Donielle McCutcheon

dmccutcheon@sidley.com

芝加哥+1 312 853 7282

合伙人律师

Catherine Y. Starks

cstarks@sidley.com

芝加哥+1 312 853 0579

合伙人律师

Trevor L. Wear

twear@sidley.com

芝加哥+1 312 853 7101

Related Capabilities

• 食品、药品及医疗器械监管
• 卫生保健报销
• 全球生命科学
• 医疗保健